ISSN 1518 0557
Piperine protects ovarian follicles and stromal cells against doxorubicin-induced adverse effects in mouse ovaries

2026; 30
Moisés Bruno Marinho Rocha, Ernando Igo Teixeira de Assis, Venância Antônia Nunes Azevedo, Miguel Fernandes de Lima Neto, Anderson Weiny Barbalho Silva, Alana Nogueira Godinho, Jordânia Marques de Oliveria Freire, Emanoel da Silva Félix, Regislane Pinto Ribeiro, Geovany Amorim Gomes, José Roberto Viana Silva
JBRA Assist. Reprod. 2026; 30 (1):79-88

Received July 12, 2025
Accepted February 20, 2026
Abstract

Objective: This study investigates the effects of Piperine (PIP) on doxorubicin (DOX)-induced changes in mouse ovarian follicles, stromal cells, collagen fibers, and mRNA expression of nuclear factor erythroid 2-related factor (NRF2), superoxide dismutase (SOD), and catalase (CAT). Methods: The mice were randomly divided into seven groups. In the first three groups, they received saline (1), both DOX and N-acetylcysteine (2), or DOX only (3). In groups 4 and 5, mice were treated with DOX in combination with 0.1 or 10.0 mg/kg PIP. In groups 6 and 7, mice received 0.1 or 10.0 mg/kg PIP alone. After 10 days, ovaries were collected and used to evaluate follicular morphology and growth, collagen fibers, stromal cells, and mRNA for NRF2, SOD, and CAT. Results: Mice treated with DOX showed reduced percentage of normal follicles, but the combination of DOX with PIP or NAC prevented this effect, maintaining follicle integrity similar to untreated animals. Ovaries of mice treated with PIP alone had similar percentage of normal follicles compared to control group. Additionally, the association of DOX and PIP preserved collagen levels similar to control, while PIP or NAC alone did not influence collagen distribution. Ovaries of mice treated with both DOX and NAC showed a reduction in stromal cells, but those treated with both DOX and PIP maintained the levels of collagens similar to control. Conclusions: The DOX and PIP preserved the integrity of follicles and collagen fibers in mouse ovaries, which opens a new possibility to protect primordial follicles during chemotherapy.


This Article

doi: 10.5935/1518-0557.20250187

Full Text (HTML)
Full Text (PDF)

Classifications

Original article

Send this article

Send this article by mail

Access statistics

Last 30 days: 54
All time: 559


Home

 
Copyright 2026 - JBRA Assisted Reproduction - All rights reserved.
Support and Maintenance by Eniosoft